Clinical trial
Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma
NCT04577326
Study timeline
Study start (actual)2020-09-30Date precision: day
Registry last updated2026-07-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Malignant Pleural Mesothelioma (MPM)unresolved
Interventions
cyclophosphamideDRUG · verified · RxNorm: cyclophosphamide
CAR T cellsBIOLOGICAL
Sponsors & collaborators
Memorial Sloan Kettering Cancer Centerlead sponsor
Atara Biotherapeuticscollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04577326 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.